NO992526L - Cephalosporin derivatives - Google Patents
Cephalosporin derivativesInfo
- Publication number
- NO992526L NO992526L NO992526A NO992526A NO992526L NO 992526 L NO992526 L NO 992526L NO 992526 A NO992526 A NO 992526A NO 992526 A NO992526 A NO 992526A NO 992526 L NO992526 L NO 992526L
- Authority
- NO
- Norway
- Prior art keywords
- group
- halogen
- hydrogen
- derivatives
- alkyl group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Det beskrives cephem-derivater med den generelle formel V/? CH2-S-Q COOR1 hvor Q er en eventuelt substituert pyridiniumgruppe forbundet med svovelatomet via et ringkarbonatom; X er halogen; Y er hydrogen eller halogen; L1 er en furangruppe, en tiofengruppe, en C2-Ci0-alkylgruppe, eller en C2-Cio-alkylgruppe avbrutt av en eller flere grupper uavhengig valgt fra vinyl, S, SO, S02, S02NH, H eller xNxri/' H o n er O eller 1; A er C02H, P03H2, S03H eller tetrazol; og R1 er hydrogen eller en karboksyl-beskyttende gruppe; og farmasøytisk akseptable salter og/eller prodrugs derav. Derivatene er grampositive antibakterielle midler spesielt egnet til behandlingen av sykdommer forårsaket av methicillin-resistent Staphylococcus aureus (MRSA).Cephem derivatives of the general formula V /? CH2-S-Q COOR1 wherein Q is an optionally substituted pyridinium group connected to the sulfur atom via a ring carbon atom; X is halogen; Y is hydrogen or halogen; L1 is a furan group, a thiophene group, a C2-C10 alkyl group, or a C2-C10 alkyl group interrupted by one or more groups independently selected from vinyl, S, SO, SO2, SO2 NH, H or xNxri / H on is O or 1; A is CO 2 H, PO 3 H 2, SO 3 H or tetrazole; and R 1 is hydrogen or a carboxyl protecting group; and pharmaceutically acceptable salts and / or prodrugs thereof. The derivatives are gram-positive antibacterial agents particularly suitable for the treatment of diseases caused by methicillin-resistant Staphylococcus aureus (MRSA).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3404696P | 1996-11-27 | 1996-11-27 | |
PCT/US1997/021785 WO1998023621A1 (en) | 1996-11-27 | 1997-11-21 | Cephalosporin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992526D0 NO992526D0 (en) | 1999-05-26 |
NO992526L true NO992526L (en) | 1999-05-26 |
Family
ID=21873971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992526A NO992526L (en) | 1996-11-27 | 1999-05-26 | Cephalosporin derivatives |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0966472A1 (en) |
JP (1) | JP2001506607A (en) |
KR (1) | KR20000057283A (en) |
CN (1) | CN1238775A (en) |
AR (1) | AR010650A1 (en) |
AU (1) | AU734948B2 (en) |
BR (1) | BR9713350A (en) |
CA (1) | CA2272717A1 (en) |
CZ (1) | CZ185399A3 (en) |
HU (1) | HUP9903621A3 (en) |
IL (1) | IL129437A0 (en) |
NO (1) | NO992526L (en) |
NZ (1) | NZ335892A (en) |
PL (1) | PL334558A1 (en) |
TW (1) | TW414796B (en) |
WO (1) | WO1998023621A1 (en) |
ZA (1) | ZA9710662B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265394B1 (en) * | 1997-07-31 | 2001-07-24 | Bristol-Myers Squibb Company | Bis quaternary MRSA cephem derivatives |
KR20020085181A (en) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | Novel cephalosporin antibiotics and process for preparing same |
KR20020085180A (en) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | Novel cephalosporin antibiotics and process for preparing same |
KR20020085176A (en) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | Novel cephalosporin antibiotics and process for preparing same |
KR20020085178A (en) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | Novel cephalosporin antibiotics and process for preparing same |
KR20030071311A (en) * | 2002-02-28 | 2003-09-03 | 주식회사 엘지생명과학 | Novel cephalosporin compounds and process for preparing the same |
MX2013013211A (en) * | 2011-05-18 | 2014-02-20 | Syngenta Participations Ag | Insecticidal compounds based on arylthioacetamide derivatives. |
CN105131018B (en) * | 2015-09-23 | 2017-12-26 | 浙江华方药业股份有限公司 | A kind of preparation method of ceftezole acid |
CN114957056A (en) * | 2021-02-20 | 2022-08-30 | 帕潘纳(北京)科技有限公司 | Process for preparing methyl 3-methyl-2-chloro-4-methylsulfonylbenzoate and intermediates thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3345366A (en) * | 1967-02-15 | 1967-10-03 | American Cyanamid Co | Substituted 7-acetylamino cephalosporanic acids |
US4148997A (en) * | 1977-11-07 | 1979-04-10 | Yeda Research And Development Co., Ltd. | 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives |
US5567698A (en) * | 1995-02-15 | 1996-10-22 | Bristol-Myers Squibb Company | Pyridinium thiomethyl substituted chepholosporin derivatives |
US5620969A (en) * | 1995-04-25 | 1997-04-15 | Bristol-Myers Squibb Company | Cephalosporin derviatives |
AU1278197A (en) * | 1995-12-20 | 1997-07-14 | Bristol-Myers Squibb Company | Cephalosporin derivatives |
-
1997
- 1997-11-19 TW TW086117285A patent/TW414796B/en not_active IP Right Cessation
- 1997-11-21 WO PCT/US1997/021785 patent/WO1998023621A1/en not_active Application Discontinuation
- 1997-11-21 JP JP52485698A patent/JP2001506607A/en active Pending
- 1997-11-21 CZ CZ991853A patent/CZ185399A3/en unknown
- 1997-11-21 CA CA002272717A patent/CA2272717A1/en not_active Abandoned
- 1997-11-21 IL IL12943797A patent/IL129437A0/en unknown
- 1997-11-21 PL PL97334558A patent/PL334558A1/en unknown
- 1997-11-21 EP EP97950724A patent/EP0966472A1/en not_active Ceased
- 1997-11-21 AU AU53652/98A patent/AU734948B2/en not_active Ceased
- 1997-11-21 NZ NZ335892A patent/NZ335892A/en unknown
- 1997-11-21 HU HU9903621A patent/HUP9903621A3/en unknown
- 1997-11-21 KR KR1019990704689A patent/KR20000057283A/en not_active Application Discontinuation
- 1997-11-21 BR BR9713350-7A patent/BR9713350A/en unknown
- 1997-11-21 CN CN97199930A patent/CN1238775A/en active Pending
- 1997-11-26 AR ARP970105544A patent/AR010650A1/en unknown
- 1997-11-26 ZA ZA9710662A patent/ZA9710662B/en unknown
-
1999
- 1999-05-26 NO NO992526A patent/NO992526L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0966472A1 (en) | 1999-12-29 |
KR20000057283A (en) | 2000-09-15 |
CN1238775A (en) | 1999-12-15 |
HUP9903621A3 (en) | 2001-05-28 |
AU734948B2 (en) | 2001-06-28 |
CA2272717A1 (en) | 1998-06-04 |
IL129437A0 (en) | 2000-02-17 |
BR9713350A (en) | 2000-01-25 |
NZ335892A (en) | 2001-07-27 |
AR010650A1 (en) | 2000-06-28 |
WO1998023621A1 (en) | 1998-06-04 |
CZ185399A3 (en) | 1999-08-11 |
HUP9903621A2 (en) | 2000-04-28 |
TW414796B (en) | 2000-12-11 |
ZA9710662B (en) | 1999-05-26 |
NO992526D0 (en) | 1999-05-26 |
PL334558A1 (en) | 2000-03-13 |
EP0966472A4 (en) | 1999-12-29 |
JP2001506607A (en) | 2001-05-22 |
AU5365298A (en) | 1998-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69331089T2 (en) | Beta-lactam and cepham compounds and their manufacture | |
NO992526L (en) | Cephalosporin derivatives | |
GB1526978A (en) | 3-thiosubstituted cephalosporin antibiotics | |
FI864825A (en) | CEFALOSPORINDERIVAT. | |
IE832266L (en) | Carbapenene antibiotics | |
EP0376724A3 (en) | Cephalosporin compounds | |
FI924934A0 (en) | THIRD PHTHALAZINER FOR SOME INHOLDER AND ETHER-ELLER THIOETER GRUPPERING I 1-STAELLNING OCH FOERFARANDE FOER DERAS FRAMSTAELLNING | |
EP0214600A3 (en) | Cephalosporin derivatives | |
ES455404A1 (en) | Therapeutic compounds containing beta -lactams | |
SE7709071L (en) | OLIVANIC ACID ESTERS | |
PH25378A (en) | Novel aminoalkyl-substituted heterocyclic ssulfur coumpounds | |
DE3787030D1 (en) | 1-CARBOXY-1-VINYLOXYIMINOAMINOTHIAZOLE-CEPHALOSPORINE DERIVATIVES AND THE PRODUCTION THEREOF. | |
NO171502C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE THIADIAZOLYLACETAMIDE CEFEM DERIVATIVES | |
ES2123728T3 (en) | DERIVATIVES OF PYRROLLO-PYRAZINE ACTIVITY 5-HT3. | |
ATE206426T1 (en) | CARBAPENEM DERIVATIVES | |
ES8405399A1 (en) | Carbapenem antibiotics | |
ES8507150A1 (en) | Cephalosporin derivatives, methods of production thereof and prophylactic and therapeutic agents for bacterial infection. | |
CA2155837A1 (en) | Benzopyrans as potassium channel openers | |
SE7709646L (en) | ANTIBACTERIAL AGENTS | |
SE8504538D0 (en) | CARBAPENEM ANTIBIOTICS | |
RU99113359A (en) | DERIVATIVES OF CEFALOSPORIN | |
SE8104308L (en) | NEW ASSOCIATIONS WITH ANTIBIOTIC EFFECT | |
DK366982A (en) | CEPHALOSPORINE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION | |
TH7294B (en) | Carboxylkina Mido Cephalosporin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |